-
261
Dose-volume parameter evaluation of a sub-fractionation workflow for adaptive radiotherapy of prostate cancer patients on a 1.5 T magnetic resonance imaging radiotherapy system
Published 2025-01-01Subjects: “…Prostate cancer…”
Get full text
Article -
262
-
263
Applying Focal Therapy to Lesions Detected via Magnetic Resonance Imaging: Delivering Cancer Ablation Beyond the Visibility Phenomenon
Published 2025-02-01Subjects: “…Prostate cancer…”
Get full text
Article -
264
Associations of dose to the urethra and long-term patient-reported outcomes after radiotherapy with EBRT and HDR brachytherapy boost for prostate cancer
Published 2025-03-01Subjects: “…Prostate cancer…”
Get full text
Article -
265
Physical Performance and Activity in Older Prostate Cancer Survivors in Comparison with Population-based Matched Controls
Published 2025-01-01Subjects: Get full text
Article -
266
-
267
SOX7 is involved in polyphyllin D-induced G0/G1 cell cycle arrest through down-regulation of cyclin D1
Published 2020-06-01Subjects: Get full text
Article -
268
Optimization of Wall-disruption Process of Rose Bee Pollen and Comparison of Physiological Activities of Its Ethanol Extracts
Published 2025-02-01Subjects: Get full text
Article -
269
Exercise medicine as adjunct therapy during RADIation for CAncer of the prostaTE to improve treatment efficacy – protocol for the ERADICATE study: a phase II randomised controlled...
Published 2025-01-01Subjects: “…Prostate cancer…”
Get full text
Article -
270
Heterogeneity of cancer-associated fibroblast subpopulations in prostate cancer: Implications for prognosis and immunotherapy
Published 2025-02-01Subjects: Get full text
Article -
271
-
272
-
273
Prostate cancer cells elevate glycolysis and G6PD in response to caffeic acid phenethyl ester-induced growth inhibition
Published 2025-01-01Subjects: Get full text
Article -
274
No impairment of quality of life after radiotherapy for prostate cancer
Published 2024-12-01Subjects: “…Prostate cancer…”
Get full text
Article -
275
Gut microbiota derived metabolite trimethylamine N-oxide influences prostate cancer progression via the p38/HMOX1 pathway
Published 2025-01-01Subjects: Get full text
Article -
276
Burden of benign prostatic hyperplasia in the Middle East and North Africa Region, 1990–2021
Published 2025-02-01Subjects: “…Benign prostatic hyperplasia…”
Get full text
Article -
277
Treatment decision regret after precision prostatectomy: An analysis of patient‐reported outcomes predicting decision regret
Published 2025-01-01Subjects: Get full text
Article -
278
Ultra-fast biparametric MRI in prostate cancer assessment: Diagnostic performance and image quality compared to conventional multiparametric MRI
Published 2025-06-01Subjects: “…Prostate cancer…”
Get full text
Article -
279
PHARMACOTHERAPY IN PATIENTS WITH ERECTILE DYSFUNCTION AND BENIGN PROSTATIC HYPERPLASIA IN THE ABSENCE OF RISK OF DISEASE PROGRESSION
Published 2018-03-01Subjects: “…benign prostatic hyperplasia…”
Get full text
Article -
280